| Literature DB >> 36057602 |
Paz Lotan1,2, Shayel Bercovich3,4, Daniel Keidar3,4, Kamil Malshy5,6, Ziv Savin4,7, Rennen Haramaty4,8, Jonathan Gal4,9, Jonathan Modai4,10, Dan Leibovici4,10, Roy Mano4,7, Barak Rosenzweig4,8, Azik Hoffman5,6, Miki Haifler4,8, Jack Baniel3,4, Shay Golan3,4.
Abstract
BACKGROUND: Fascial dehiscence after radical cystectomy may have serious clinical implications. To optimize its management, we sought to describe accompanying intraabdominal findings of post-cystectomy dehiscence repair and determine whether a thorough intraabdominal exploration during its operation is mandatory.Entities:
Keywords: Bladder cancer; Cystectomy; Dehiscence; Fascia; Laparotomy; Surgery
Mesh:
Year: 2022 PMID: 36057602 PMCID: PMC9441031 DOI: 10.1186/s12894-022-01095-4
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.090
Baseline characteristics of patients with fascial dehiscence after radical cystectomy
| Characteristic | Total N (%) | Patients with accompanying intra-abdominal complications | Patients without accompanying intra-abdominal complications | |
|---|---|---|---|---|
| No. of patients (%) | 27 (100) | 7 (26) | 20 (74) | |
| Gender | ||||
| Male | 26 (96) | |||
| Female | 1 (4) | |||
| Age (years) | 75 (68, 80) | 78 (72, 81) | 74 (65, 80) | 0.19 |
| Body mass index kg/m2 | 29 (26, 31) | 30 (27, 32) | 29 (26, 30) | 0.65 |
| Smoking past/present | 21 (78) | 6 (86) | 15 (75) | 0.56 |
| Diabetes melitus | 9 (33) | 4 (57) | 5 (25) | 0.12 |
| Peripheral vascular disease | 4 (15) | 1 (14) | 3 (15) | 1 |
| Ischemic heart disease | 9 (33) | 5 (71) | 4 (20) | |
| Cerebrovascular accident | 1 (4) | 1 (14) | 0 | 0.26 |
| Cardiac arrhythmia | 7 (26) | 3 (43) | 4 (20) | 0.23 |
| Steroid use | 2 (7) | 0 | 2 (10) | 1 |
| Chronic lung disease | 4 (15) | 0 | 4 (20) | 0.54 |
| Antiplatelet/anticoagulation use | 11 (41) | 5 (71) | 6 (30) | |
| Previous abdominal operation | 4 (15) | 0 | 4 (20) | 0.55 |
| Neoadjuvant chemotherapy | 6 (22) | 2 (29) | 4 (20) | 0.63 |
| Age-adjusted Charlson comorbidity index | 6 (5, 8) | 7 (6, 10) | 6 (5, 8) | 0.19 |
IQR interquartile range; Continuous variables are shown as median (IQR) and categorical variables are shown as number and percentage
Operative and postoperative parameters of radical cystectomy
| Characteristic | Total N = 27 (%) | Patients with accompanying intra-abdominal complications N = 7 | Patients without accompanying intra-abdominal complications N = 20 | |
|---|---|---|---|---|
| Type of urinary diversion | ||||
| Ileal conduit | 24 (89) | 7 (100) | 17 (85) | 0.55 |
| Orthotopic neobladder | 3 (11) | 0 | 3 (15) | |
| Operating room time (min) | 353 (275, 414) | 355 (275, 450) | 349 (264, 406) | 0.9 |
| Estimated blood loss (ml) | 500 (450, 1000) | 550 (500, 700) | 500 (425, 1000) | 0.88 |
| Admitted to the intensive care unit (post-cystectomy) | 4 (15) | 2 (29) | 2 (10) | 0.27 |
| Other preioperative complications† | 19 (70) | 5 (71) | 14 (70) | 1 |
| Respiratory failure | 2 | 1 | 1 | |
| Cerebrovascular accident | 1 | 0 | 1 | |
| Prolonged ileus | 3 | 0 | 3 | |
| Deep venous thrombosis | 2 | 1 | 1 | |
| Pneumonia | 1 | 1 | 0 | |
| Cardiac arrhythmia | 2 | 0 | 2 | |
| Urinary tract infection | 12 | 2 (29) | 10 (50) | 0.33 |
| Wound infection | 16 (59) | 5 (71) | 11 (55) | 0.12 |
| Wound pathogen resistant to preoperative anibiotics | 12 (75) | 5 (100) | 7 (64) | 0.25 |
| Post-operative day of dehiscence diagnosis | 7 (5, 10) | 10 (6, 15) | 7 (5, 9) | |
| Pre-dehiscence Albumin g/dL | 2.8 (2.5, 3.6) | 2.5 (2.2, 3.5) | 2.8 (2.6, 3.1) | 0.38 |
| Pre-dehiscence Creatinine mg/dL | 1.14 (0.9, 1.4) | 1.15 (1.1, 1.4) | 1.11 (0.85, 1.3) | 0.36 |
| Pre-dehiscence Hemoglobin g/dL | 10.2 (9.7, 11) | 9.9 (9.6, 11) | 10.3 (9.9, 11.2) | 0.38 |
| Pre-dehiscence Leukocyte count 103/µl | 10.7 (8.2, 12.8) | 11.7 (8.3, 19) | 10.6 (7.3, 12.4) | 0.2 |
| Pre-dehiscence C-reactive protein mg/dL | 12.4 (9.2, 18.7) | 19.8 (11.2, 22.8) | 11.6 (9.6, 13.1) | 0.2 |
| APACHE II score | 10.4 (2.9) | 10.1 (1.7) | 10.5 (3.3) | 0.8 |
Continuous variables are shown as median (IQR) and categorical variables are shown as number and percentage. APACHE score, shown as mean and standard deviation
APACHE Acute Physiology and Chronic Health Evaluation, IQR interquartile range, SD standard deviation
†Might be more than one complication per patient
Fascial dehiscence: operative and postoperative parameters
| Characteristic | Total N = 27 | Patients with accompanying intra-abdominal complications N = 7 | Patients without accompanying intra-abdominal complications N = 20 | |
|---|---|---|---|---|
| Length of laparotomy (minutes) | 60 (49, 98) | 60 (60, 115) | 64 (47, 89) | 0.3 |
| Type of complication† | ||||
| Anastomotic ureteral dehiscence | 4 (15) | |||
| Ileal conduit perforation | 1 (4) | |||
| Infected collection/abscess | 1 (4) | |||
| Gastrointestinal anastomotic leakage | 1 (4) | |||
| Internal hernia | 1 (4) | |||
| Primary fascial closure | 25 (93) | 5 (71) | 20 (100) | |
| Perioperative complications | 10 (37) | 3 (43) | 7 (35) | 1 |
| Admitted to ICU (post-laparotomy) | 7 (26) | 3 (43) | 4 (20) | 0.33 |
| No. of days in ICU | 7 (1.5, 7.5) | 8 (4.5, 19.5) | 4.5 (1.8, 7) | 0.32 |
| Length of hospital stay | 23 (17, 29) | 41 (29, 47) | 20.5 (17, 23.5) | |
| Late complications | 5 (19) | 1 (14) | 4 (20) | 1 |
| Perioperative mortality | 3 (11) | 1 (14) | 2 (10) | 1 |
| Total mortality during follow-up | 13 (48) | 2 (29) | 11 (55) | 0.4 |
Continuous variables are shown as median (IQR) and categorical variables are shown as number and percentage
ICU intensive care unit, IQR interquartile range
†Might be more than one complication per patient